These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32208231)

  • 1. Adherence to exposure and response prevention as a predictor of improvement in obsessive-compulsive symptom dimensions.
    Ojalehto HJ; Abramowitz JS; Hellberg SN; Buchholz JL; Twohig MP
    J Anxiety Disord; 2020 May; 72():102210. PubMed ID: 32208231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adding acceptance and commitment therapy to exposure and response prevention for obsessive-compulsive disorder: A randomized controlled trial.
    Twohig MP; Abramowitz JS; Smith BM; Fabricant LE; Jacoby RJ; Morrison KL; Bluett EJ; Reuman L; Blakey SM; Ledermann T
    Behav Res Ther; 2018 Sep; 108():1-9. PubMed ID: 29966992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between obsessive beliefs and symptom dimensions in obsessive-compulsive disorder.
    Wheaton MG; Abramowitz JS; Berman NC; Riemann BC; Hale LR
    Behav Res Ther; 2010 Oct; 48(10):949-54. PubMed ID: 20800750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Not just thinking, but believing: Obsessive beliefs and domains of cognitive fusion in the prediction of OCD symptom dimensions.
    Hellberg SN; Buchholz JL; Twohig MP; Abramowitz JS
    Clin Psychol Psychother; 2020 Jan; 27(1):69-78. PubMed ID: 31657499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive Mediation of Symptom Change in Exposure and Response Prevention for Obsessive-Compulsive Disorder.
    Su YJ; Carpenter JK; Zandberg LJ; Simpson HB; Foa EB
    Behav Ther; 2016 Jul; 47(4):474-86. PubMed ID: 27423164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the addition of cognitive therapy to exposure and response prevention for obsessive compulsive disorder enhance clinical efficacy? A randomized controlled trial in a community setting.
    Rector NA; Richter MA; Katz D; Leybman M
    Br J Clin Psychol; 2019 Mar; 58(1):1-18. PubMed ID: 29984550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How willing are you? Willingness as a predictor of change during treatment of adults with obsessive-compulsive disorder.
    Reid AM; Garner LE; Van Kirk N; Gironda C; Krompinger JW; Brennan BP; Mathes BM; Monaghan SC; Tifft ED; André MC; Cattie J; Crosby JM; Elias JA
    Depress Anxiety; 2017 Nov; 34(11):1057-1064. PubMed ID: 28715850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Online Video Teletherapy Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention: Clinical Outcomes From a Retrospective Longitudinal Observational Study.
    Feusner JD; Farrell NR; Kreyling J; McGrath PB; Rhode A; Faneuff T; Lonsway S; Mohideen R; Jurich JE; Trusky L; Smith SM
    J Med Internet Res; 2022 May; 24(5):e36431. PubMed ID: 35587365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bifactor model of obsessive beliefs: Specificity in the prediction of obsessive-compulsive disorder symptoms.
    Olatunji BO; Ebesutani C; Tolin DF
    Psychol Assess; 2019 Feb; 31(2):210-225. PubMed ID: 30307265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mindfulness-based exposure and response prevention for obsessive compulsive disorder: Findings from a pilot randomised controlled trial.
    Strauss C; Lea L; Hayward M; Forrester E; Leeuwerik T; Jones AM; Rosten C
    J Anxiety Disord; 2018 Jun; 57():39-47. PubMed ID: 29739634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiential avoidance in symptom dimensions of OCD.
    Wetterneck CT; Steinberg DS; Hart J
    Bull Menninger Clin; 2014; 78(3):253-69. PubMed ID: 25247744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fear of Self and Unacceptable Thoughts in Obsessive-Compulsive Disorder.
    Melli G; Aardema F; Moulding R
    Clin Psychol Psychother; 2016 May; 23(3):226-35. PubMed ID: 25772861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Suitability of Different Subtypes and Dimensions of Obsessive-Compulsive Disorder for Treatment with Anterior Capsulotomy: A Long-Term Follow-Up Study.
    Gong F; Li B; Zhang S; Wang Y; Gao Y; Xu Y; Wang X; Xiong B; Li D; Wen R; Qin Z; Wang W
    Stereotact Funct Neurosurg; 2019; 97(5-6):319-336. PubMed ID: 31786574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EFFECTS OF HOMEWORK COMPLIANCE ON COGNITIVE-BEHAVIORAL THERAPY WITH D-CYCLOSERINE AUGMENTATION FOR CHILDREN WITH OBSESSIVE COMPULSIVE DISORDER.
    Olatunji BO; Rosenfield D; Monzani B; Krebs G; Heyman I; Turner C; Isomura K; Mataix-Cols D
    Depress Anxiety; 2015 Dec; 32(12):935-43. PubMed ID: 26372401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom dimensions in obsessive-compulsive disorder: phenomenology and treatment outcomes with exposure and ritual prevention.
    Williams MT; Mugno B; Franklin M; Faber S
    Psychopathology; 2013; 46(6):365-76. PubMed ID: 23615340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of D-Cycloserine on the Effect of Concentrated Exposure and Response Prevention in Difficult-to-Treat Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
    Kvale G; Hansen B; Hagen K; Abramowitz JS; Børtveit T; Craske MG; Franklin ME; Haseth S; Himle JA; Hystad S; Kristensen UB; Launes G; Lund A; Solem S; Öst LG
    JAMA Netw Open; 2020 Aug; 3(8):e2013249. PubMed ID: 32789516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of cognitive-behavioral therapy for obsessive-compulsive disorder.
    McKay D; Sookman D; Neziroglu F; Wilhelm S; Stein DJ; Kyrios M; Matthews K; Veale D;
    Psychiatry Res; 2015 May; 227(1):104-13. PubMed ID: 25937054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obsessive-compulsive symptoms: the contribution of obsessional beliefs and experiential avoidance.
    Abramowitz JS; Lackey GR; Wheaton MG
    J Anxiety Disord; 2009 Mar; 23(2):160-6. PubMed ID: 18657382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Exposure and Response Prevention Behaviorally Activate Patients With Obsessive-Compulsive Disorder? A Preliminary Test.
    Blakey SM; Abramowitz JS; Leonard RC; Riemann BC
    Behav Ther; 2019 Jan; 50(1):214-224. PubMed ID: 30661561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serious negative consequences associated with exposure and response prevention for obsessive-compulsive disorder: A survey of therapist attitudes and experiences.
    Schneider SC; Knott L; Cepeda SL; Hana LM; McIngvale E; Goodman WK; Storch EA
    Depress Anxiety; 2020 May; 37(5):418-428. PubMed ID: 32048376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.